Brennan Johnson, Ph.D.

RESEARCH SUMMARY

I received my Ph.D. in cancer cell biology in 2022. As a doctorate student I focused on defining the role ERO1α in EGFR-driven Non-Small Cell Lung Cancer (NSCLC) and potential strategies for targeting it therapeutically.

I joined Dr. Yang’s lab to determine mechanisms of how the immune system affects tumor dormancy in breast cancer. I am currently employing cutting-edge technology such as scRNA-seq, scATAC-seq, and transgenic mouse models to determine the role of the immune system; specifically, how myeloid cells contribute to tumor dormancy.

Areas of Expertise